The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-methoxy-3,8-dimethyl-N-(2-(pyridin-4-yl)ethyl)-1H-pyrazolo[3,4-b]quinolin-4-amine ID: ALA1939802
PubChem CID: 46239835
Max Phase: Preclinical
Molecular Formula: C20H21N5O
Molecular Weight: 347.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(C)c2nc3[nH]nc(C)c3c(NCCc3ccncc3)c2c1
Standard InChI: InChI=1S/C20H21N5O/c1-12-10-15(26-3)11-16-18(12)23-20-17(13(2)24-25-20)19(16)22-9-6-14-4-7-21-8-5-14/h4-5,7-8,10-11H,6,9H2,1-3H3,(H2,22,23,24,25)
Standard InChI Key: SDYQZLQJADODFL-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
8.3194 -24.6583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3182 -25.4857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0331 -25.8985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0313 -24.2455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7466 -24.6547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7474 -25.4815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4627 -25.8925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4571 -24.2405 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1730 -24.6477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1807 -25.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9739 -25.7288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4565 -25.0515 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9614 -24.3835 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2362 -26.5110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0288 -23.4205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6034 -25.8976 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8940 -25.4845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4630 -26.7175 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1777 -27.1297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1780 -27.9547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8926 -28.3669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8892 -29.1927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6030 -29.6049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3183 -29.1921 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.3153 -28.3628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6010 -27.9544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 12 2 0
12 13 1 0
13 9 1 0
3 6 2 0
11 14 1 0
6 7 1 0
4 15 1 0
7 10 2 0
2 16 1 0
1 2 2 0
16 17 1 0
9 8 2 0
7 18 1 0
8 5 1 0
18 19 1 0
9 10 1 0
19 20 1 0
5 4 2 0
20 21 1 0
4 1 1 0
21 22 2 0
22 23 1 0
2 3 1 0
23 24 2 0
5 6 1 0
24 25 1 0
10 11 1 0
25 26 2 0
26 21 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 347.42Molecular Weight (Monoisotopic): 347.1746AlogP: 3.79#Rotatable Bonds: 5Polar Surface Area: 75.72Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.46CX Basic pKa: 5.62CX LogP: 2.58CX LogD: 2.57Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.57Np Likeness Score: -1.03
References 1. Ho GD, Yang SW, Smotryski J, Bercovici A, Nechuta T, Smith EM, McElroy W, Tan Z, Tulshian D, McKittrick B, Greenlee WJ, Hruza A, Xiao L, Rindgen D, Mullins D, Guzzi M, Zhang X, Bleickardt C, Hodgson R.. (2012) The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia., 22 (2): [PMID:22222034 ] [10.1016/j.bmcl.2011.11.127 ]